However, many industry insiders say these
changes are opening up unique opportunities for researchers who focus on translating basic science into real - world cures and are eager
to explore the
molecular mechanisms of disease, test hypotheses, and do work that
benefits patients.
Yet it is still too early in our investigation into the epigenetics of this complex stress - response system
to know for sure whether these
molecular changes indicate any real - world risks or
benefits.